1203 studies found for:    "Retinoschisis" OR "Retinal Degeneration" OR "X-linked juvenile retinoschisis"
Show Display Options
Rank Status Study
21 Completed Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
Conditions: Healthy;   Muscular Dystrophy;   Retinal Degeneration;   Skin Diseases;   Virus Diseases
Intervention:
22 Recruiting Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Conditions: Inherited Ophthalmic Diseases;   Inherited Retinal Degeneration
Intervention: Drug: Interferon gamma-1b
23 Recruiting X-82 to Treat Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration (AMD);   Macular Degeneration;   Exudative Age-related Macular Degeneration;   AMD;   Macular Degeneration, Age-related, 10;   Eye Diseases;   Retinal Degeneration;   Retinal Diseases
Interventions: Drug: X-82;   Drug: Aflibercept;   Drug: Placebo
24 Recruiting Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.
Conditions: Retinal Degeneration;   Primary Open-angle Glaucoma
Interventions: Procedure: Intravitreal transplantation of mesenchymal stem cell;   Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
25 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept
26 Unknown  Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
27 Active, not recruiting Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Age-Related Maculopathies;   Age-Related Maculopathy;   Maculopathies, Age-Related;   Maculopathy, Age-Related;   Retinal Degeneration;   Retinal Neovascularization;   Gene Therapy;   Therapy, Gene;   Eye Diseases
Intervention: Biological: AAV2-sFLT01
28 Completed Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
29 Completed
Has Results
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
30 Completed
Has Results
A Multi-Center Study of Reading Rehabilitation in Macular Disease
Conditions: Age Related Maculopathy;   Retinal Degeneration
Interventions: Behavioral: Module 1: Visual Awareness and Eccentric Viewing;   Behavioral: Module 2: Control of Reading Eye Movements;   Behavioral: Module 3: Reading Practice with RSVP
31 Completed Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
Conditions: Retinal Degeneration;   Diabetic Retinopathy
Intervention:
32 Completed Measuring Reading Rehabilitation Outcomes
Conditions: Age Related Maculopathy;   Retinal Degeneration
Intervention: Procedure: Eccentric Viewing Training for Reading
33 Enrolling by invitation Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinal Degeneration,;   Retinitis Pigmentosa
Intervention: Procedure: surgical implantation of subretinal device
34 Recruiting Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Conditions: Outer Retinal Degeneration;   Retinitis Pigmentosa
Intervention:
35 Recruiting Retinal Imaging in Patients With Inherited Retinal Degenerations
Condition: Retinitis Pigmentosa
Intervention:
36 Active, not recruiting A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
Condition: Stargardt Disease
Intervention:
37 Recruiting High Resolution Retinal Imaging
Conditions: Stargardts;   Retinitis Pigmentosa;   Age-related Macular Degeneration;   Choroideremia;   Geographic Atrophy
Intervention: Procedure: Retinal imaging
38 Terminated A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Conditions: Age Related Macular Degeneration;   Choroidal Neovascular Membrane;   Subfoveal Neovascular Age-Related Macular Degeneration;   Macular Degeneration;   Wet Age-Related Macular Degeneration
Intervention: Drug: Ranibizumab
39 Completed Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: ranibizumab, dexamethasone and verteporfin;   Drug: Ranibizumab
40 Unknown  Long-Term Efficacy in AMD of Rheopheresis in North America
Condition: Macular Degeneration
Intervention: Device: Rheopheresis blood filtration

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years